NCT06992622 Zhejiang Adolescent Spine and Vision Health Cohort: A Longitudinal Database Analysis
| NCT ID | NCT06992622 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Affiliated Hospital of Wenzhou Medical University |
| Condition | Scoliosis Idiopathic |
| Study Type | OBSERVATIONAL |
| Enrollment | 73,000 participants |
| Start Date | 2024-09-30 |
| Primary Completion | 2032-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 73,000 participants in total. It began in 2024-09-30 with a primary completion date of 2032-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of study: 1. To investigate the prevalence of scoliosis, other spinal deformities, myopia, and visual impairments in adolescents (aged 6-18) in Zhejiang Province. 2.To track 8-year dynamic changes in spinal curvature and analyze associations between scoliosis, vision disorders, and potential risk factors. 3.To deliver scoliosis health education during screenings. 4.To mitigate scoliosis progression through early detection and intervention.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of idiopathic scoliosis at their first clinic visit * Skeletally immature (Risser Sign 0-3) * Cobb angle between 11-40 degrees * Age between 6 and 17 Exclusion Criteria: * • Patients with scoliosis other than idiopathic, or with other musculoskeletal or neurodevelopmental conditions that might be responsible for the scoliosis * History of previous spine surgery or spinal injury * Tumor or malignant tumor in the spine * Leg length discrepancy more than 20 mm * Previous diagnosis or treatment of SDB more than 6 months ago * Plans to relocate within the next 24 months
Contact & Investigator
Xiangyang Wang
STUDY CHAIR
Second Affiliated Hospital of Wenzhou Medical University
Frequently Asked Questions
Who can join the NCT06992622 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 17 Years, studying Scoliosis Idiopathic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06992622 currently recruiting?
Yes, NCT06992622 is actively recruiting participants. Contact the research team at Xiangyangwang@wmu.edu.cn for enrollment information.
Where is the NCT06992622 trial being conducted?
This trial is being conducted at Wenzhou, China.
Who is sponsoring the NCT06992622 clinical trial?
NCT06992622 is sponsored by Second Affiliated Hospital of Wenzhou Medical University. The principal investigator is Xiangyang Wang at Second Affiliated Hospital of Wenzhou Medical University. The trial plans to enroll 73,000 participants.